tiprankstipranks
Trending News
More News >
Leap Therapeutics Inc (LPTX)
NASDAQ:LPTX
US Market

Leap Therapeutics (LPTX) Financial Statements

Compare
895 Followers

Leap Therapeutics Financial Overview

Leap Therapeutics's market cap is currently $15.11M. The company's EPS TTM is $-0.37; its P/E ratio is ―; Leap Therapeutics is scheduled to report earnings on May 13, 2025, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 1.50M$ 1.50M
Gross Profit$ 0.00$ -427.00K$ -415.00K$ 1.50M$ 1.50M
Operating Income$ -70.06M$ -87.04M$ -56.76M$ -41.43M$ -28.54M
EBITDA$ -70.06M$ -80.99M$ -53.98M$ -40.01M$ -26.81M
Net Income$ -67.79M$ -81.41M$ -54.60M$ -40.59M$ -27.51M
Balance Sheet
Cash & Short-Term Investments$ 47.25M$ 70.64M$ 65.50M$ 114.92M$ 52.07M
Total Assets$ 49.12M$ 72.83M$ 70.35M$ 117.91M$ 54.37M
Total Debt$ 266.00K$ 262.00K$ 678.00K$ 469.00K$ 552.00K
Net Debt$ -46.98M$ -70.38M$ -64.82M$ -114.45M$ -51.52M
Total Liabilities$ 14.08M$ 12.68M$ 11.49M$ 10.02M$ 7.72M
Stockholders' Equity$ 35.05M$ 60.14M$ 58.87M$ 107.89M$ 46.65M
Cash Flow
Free Cash Flow$ -60.30M$ -43.75M$ -49.04M$ -35.16M$ -25.96M
Operating Cash Flow$ -60.30M$ -43.75M$ -49.04M$ -35.16M$ -25.96M
Investing Cash Flow$ 0.00$ 48.97M$ 0.00$ 0.00$ 25.00K
Financing Cash Flow$ 37.18M$ -30.00K$ -210.00K$ 98.03M$ 74.00M
Currency in USD

Leap Therapeutics Earnings and Revenue History

Leap Therapeutics Debt to Assets

Leap Therapeutics Cash Flow

Leap Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis